SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK

NCT ID: NCT03313687

Last Updated: 2021-10-07

Basic Information

• Recruitment Status: RECRUITING
• Total Enrollment: 2500 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2017-09-01
• Study Completion Date: 2031-12-31

Brief Summary

International, observational registry to investigate the outcome in patients with cardiogenic shock. The primary aim of this study is to investigate the clinical outcome of patients in cardiogenic shock.

Detailed Description

There is a focus on interventional therapies, mechanical circulatory support and new cardiovascular therapeutics in patients with cardiogenic shock (CS). The investigators will describe current practice in study sites including concomitant patients with CS. Therefore, the investigators will monitor drug therapies initiated, devices being utilized as well as outcome and side effect of possible interventions

Conditions

Cardiogenic Shock

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: RETROSPECTIVE

Eligibility Criteria

Inclusion Criteria

• Patients with cardiogenic shock treated at a tertiary care hospital.

Exclusion Criteria

• Age ≤17 years.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Universitätsklinikum Hamburg-Eppendorf

OTHER

Sponsor Role: lead

Responsible Party

PD Dr. Dirk Westermann

Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Dirk Westermann, MD

Role: PRINCIPAL_INVESTIGATOR

UHZ

Locations

University Heart Center

Hamburg, , Germany

Site Status: RECRUITING

Countries

Germany

Central Contacts

Benedikt Schrage, MD

Role: CONTACT

b.schrage@uke.de

+49 40 7410 18135

Dirk Westermann, MD

Role: CONTACT

d.westermann@uke.de

+49 40 7410 54864

Facility Contacts

Dirk Westermann, MD

Role: primary

Benedikt Schrage, MD

Role: backup

References

Schrage B, Ibrahim K, Loehn T, Werner N, Sinning JM, Pappalardo F, Pieri M, Skurk C, Lauten A, Landmesser U, Westenfeld R, Horn P, Pauschinger M, Eckner D, Twerenbold R, Nordbeck P, Salinger T, Abel P, Empen K, Busch MC, Felix SB, Sieweke JT, Moller JE, Pareek N, Hill J, MacCarthy P, Bergmann MW, Henriques JPS, Mobius-Winkler S, Schulze PC, Ouarrak T, Zeymer U, Schneider S, Blankenberg S, Thiele H, Schafer A, Westermann D. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock. Circulation. 2019 Mar 5;139(10):1249-1258. doi: 10.1161/CIRCULATIONAHA.118.036614.

Reference Type: DERIVED

PMID: 30586755 (View on PubMed)

Other Identifiers

STOP-SHOCK

Identifier Type: -

Identifier Source: org_study_id